NOV 11, 2021 8:00 AM PST

The Taconic-Cyagen Academic Model Generation Alliance

SPONSORED BY: Cyagen

With more than 15 years of experience in genetic engineering, Cyagen utilizes a highly efficient process, including proprietary AI technology, to design and deliver novel genetically engineered models with precision and competitive pricing, allowing researchers worldwide to create, manage, and monitor models with ease.

Taconic Biosciences provides the best solutions for the generation and supply of novel genetically engineered models by leveraging the most comprehensive, fully licensed gene modification toolkit in the industry.

The Taconic-Cyagen Academic Model Generation Alliance (The Alliance) has capabilities to ensure the success of any project. The Alliance provides specially-tailored products and services for the academic and non-profit markets. Together, we have streamlined the model design process to provide the academic market access to premium model generation and colony management services backed by comprehensive capabilities and cutting-edge, fully licensed technologies with competitive pricing.

As partners, Taconic and Cyagen leverage the power of our complementary approaches to redefine the customer’s experience with custom model generation by bringing the best and most competitive solutions for their projects.

The Complete Solution for Academic Model Generation

The Alliance redefines what non-profit researchers can expect from a custom model generation service provider and partner. What this means for you is a full catalog of cost effective, guaranteed model generation services, and access to accelerated timelines and downstream comprehensive breeding services. Multiple delivery options that allow for direct import into your facility mitigate quarantine and cost concerns associated with traditional importation*.

Academic Model Generation Benefits of the Alliance

Integration from Start to Finish

1. Fast Project Scoping: the Alliance can leverage AI-powered processes to generate quotes for your project as fast as 2 business days.

2. Cost Effective, Guaranteed Model Generation: Each project with the alliance comes with a guaranteed deliverable to facilitate discovery. We are also aware of the budgetary constraints non-profit researchers may face and aim to maximize the value of each project.

3. Comprehensive Capabilities: The Alliance provides researchers with access to a comprehensive toolkit of technologies, including but not limited to: CRISPR/Cas9, transgenic technology, PiggyBac, and embryonic stem cell (ESC)-based homologous recombination (HR).

4. Flexible Delivery Options: With a variety of delivery and rederivation options, The Alliance can deliver your model to your vivarium without the need for quarantine no matter your vivarium's restrictions*.

5. Access to Accelerated Timelines: With the ability to rapidly generate age matched cohorts of 20-40+ animals at any Taconic health standard, the Alliance can drastically reduce time spent on conventional breeding strategies.

Alliance Academic Model Generation Capabilities

1. Knockouts (KO)

2. Conditional Knockouts and Knock-ins (cKO/cKI)

3. Point Mutation Knock-ins

4. Large-fragment Knock-ins (LFKI)

5. Humanization

6. Transgenics

The Alliance provides researchers with access to a comprehensive toolkit of technologies, including but not limited to: CRISPR/Cas9, transgenic technology, PiggyBac, and embryonic stem cell (ESC)-based homologous recombination (HR).

Partner with Us for Your Next Project

With access to Taconic’s expertise, quality, and flexibility, now combined with Cyagen’s speed, efficiency, and economical business model, our team will guide you through the process to the best technical solution, service level, and deliverable for your study.

To learn how The Alliance can get to work on your research, request a consultation for a custom model design today. Tell us about your research and goals, timeline, and budget, and let our expert partner with you on your next study.

 

About the Sponsor
  • Cyagen is a 700-employee company headquartered in Santa Clara, California, with additional locations in Japan and China. As a leading provider of complete research model solutions, we offer a “one-stop-shop” tailored to biomedical scientists’ gene research needs. Our custom murine model generation services range from DNA vector construction to embryonic stem cell manipulation, microinjection, breeding, and more. All projects are fully customizable and flexible.
You May Also Like
DEC 15, 2021
Drug Discovery & Development
New study launches Viagra into the spotlight as the next drug to treat Alzheimer's disease
DEC 15, 2021
New study launches Viagra into the spotlight as the next drug to treat Alzheimer's disease
A recent study, published in the journal Nature Aging, reaffirmed the role of Sildenafil (brand name Viagra) in tre ...
DEC 24, 2021
Coronavirus
COVID-19 Tests & What to do About a Positive Result
DEC 24, 2021
COVID-19 Tests & What to do About a Positive Result
There are several types of tests for COVID-19. A laboratory test for SARS-CoV-2 (the virus that causes COVID-19) will te ...
DEC 27, 2021
Earth & The Environment
Weekend Flooding in Brazil Bursts Two Dams
DEC 27, 2021
Weekend Flooding in Brazil Bursts Two Dams
Floods this weekend caused destruction in Brazil. Two dams failed after weeks of rain in the Brazilian state of Bahia, o ...
DEC 29, 2021
Microbiology
H5N1 Avian Flu ID'ed in a Variety of Bird Populations Worldwide
DEC 29, 2021
H5N1 Avian Flu ID'ed in a Variety of Bird Populations Worldwide
There are many types of influenza virus, which are classified based on the proteins expressed on their surfaces. The H5N ...
JAN 05, 2022
Technology
A Digital Therapeutic for IBS Pain Management?
JAN 05, 2022
A Digital Therapeutic for IBS Pain Management?
Digital therapeutics (DTx) continue to rise in prevalence and scientific efficacy. While technology is nothing new in he ...
JAN 13, 2022
Cancer
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
JAN 13, 2022
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
The American Cancer Society estimates the lifetime risk of pancreatic cancer at about 1 in 64. Pancreatic duct ...
Loading Comments...